- Home
- MDIA vs NSRX Comparison
MDIA vs NSRX Comparison
Compare MDIA & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDIA | NSRX |
|---|---|---|
| Founded | 2019 | 2019 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.0M | 53.5M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | MDIA | NSRX |
|---|---|---|
| Price | $0.62 | $5.06 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.50 |
| AVG Volume (30 Days) | ★ 38.7K | 2.7K |
| Earning Date | 03-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $95,571,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 195.05 | N/A |
| 52 Week Low | $0.54 | $4.90 |
| 52 Week High | $1.60 | $9.99 |
Technical Indicators
Market Signals| Indicator | MDIA | NSRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.11 | 40.31 |
| Support Level | $0.56 | N/A |
| Resistance Level | $0.65 | $6.39 |
| Average True Range (ATR) | 0.05 | 0.73 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 51.50 | 10.78 |
Price Performance
Historical ComparisonAbout MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.
About NSRX Nasus Pharma Ltd. Ordinary Shares
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.